Biopharmaceutical company Neurocrine Biosciences has selected Ruder Finn as its communications agency of record. The ...

Global brands are shifting their agency remuneration models to pay for outputs instead of time, according to research from ...

FDA approves Lilly’s weekly insulin shot; Study finds tobacco industry spammed FDA comments opposing menthol cigarette ban; ...

The overhaul of GLP-1 marketing; The MAHA split ahead of the midterms; Roche and the future of AI in medicine.

In this episode, we explore how healthcare organizations can work with patient, consumer and HCP creators to build influence ...

The FDA approved Ultragenyx Pharmaceutical’s Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for children with ...

Amid a wave of industry consolidation, French holding company Havas occupies a unique position. While Publicis, Omnicom and ...

For Hispanic Heritage Month, marketing leaders from Cologuard and MetroPlusHealth explain why culturally relevant healthcare ...

The multiyear deal embeds real-time pricing into Epocrates' drug content. Executives call the launch a baseline and pitch it ...

The run-up to the midterm elections is turning into a food fight — literally. The summer was marred by a massive foodborne ...

Skyrizi remained the most-seen pharma brand on national TV, while Colgate surged to the top of Tubular Labs’ monthly YouTube ...

The drugmaker designed “Because Ibsrela Can” with clear, static safety visuals after studying the agency’s recent objections ...